Novos tratamentos inovadores da Gilead Sciences e AbbVie recebem aprovação positiva na Europa

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Novos tratamentos inovadores da Gilead Sciences e AbbVie recebem aprovação positiva na Europa

/jornal/2023/06/novos-tratamentos-inovadores-da-gilead-sciences-e-abbvie-recebem-aprovacao-positiva-na-europa/

Gilead DRN (BOV:GILD34)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Gilead DRN Charts.

Gilead DRN (BOV:GILD34)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Gilead DRN Charts.

News

More News Articles

Elite Pharmaceuticals (QB)

Northwest Biotherapeutics (QB)

Digital Brand Media and ... (PK)

North Bay Resources (PK)

Fannie Mae (QB)

Lightwave Logic

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions